ABVX
Price
$82.84
Change
+$0.84 (+1.02%)
Updated
Sep 26 closing price
Capitalization
6.35B
78 days until earnings call
CLSD
Price
$4.04
Change
+$0.31 (+8.31%)
Updated
Sep 26 closing price
Capitalization
21.15M
51 days until earnings call
Interact to see
Advertisement

ABVX vs CLSD

Header iconABVX vs CLSD Comparison
Open Charts ABVX vs CLSDBanner chart's image
Abivax SA
Price$82.84
Change+$0.84 (+1.02%)
Volume$767.77K
Capitalization6.35B
Clearside Biomedical
Price$4.04
Change+$0.31 (+8.31%)
Volume$99.12K
Capitalization21.15M
ABVX vs CLSD Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. CLSD commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a StrongBuy and CLSD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ABVX: $82.84 vs. CLSD: $4.04)
Brand notoriety: ABVX and CLSD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 41% vs. CLSD: 25%
Market capitalization -- ABVX: $6.35B vs. CLSD: $21.15M
ABVX [@Biotechnology] is valued at $6.35B. CLSD’s [@Biotechnology] market capitalization is $21.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileCLSD’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • CLSD’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVX is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while CLSD’s TA Score has 5 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • CLSD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CLSD is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +0.66% price change this week, while CLSD (@Biotechnology) price change was +7.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ABVX is expected to report earnings on Dec 15, 2025.

CLSD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($6.35B) has a higher market cap than CLSD($21.1M). ABVX YTD gains are higher at: 1031.694 vs. CLSD (-71.649). CLSD has less debt than ABVX: CLSD (533K) vs ABVX (92.6M).
ABVXCLSDABVX / CLSD
Capitalization6.35B21.1M30,085%
EBITDA-170.04MN/A-
Gain YTD1031.694-71.649-1,440%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash104MN/A-
Total Debt92.6M533K17,373%
FUNDAMENTALS RATINGS
CLSD: Fundamental Ratings
CLSD
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXCLSD
RSI
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 21 days ago
88%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
79%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANOGX24.130.33
+1.39%
American Century Small Cap Growth R5
RAPZX11.220.09
+0.81%
Cohen & Steers Real Assets Z
FMGIX16.590.13
+0.79%
Frontier MFG Core Infrastructure Instl
TBWCX20.280.08
+0.40%
Thornburg Better World International C
GFAFX86.620.33
+0.38%
American Funds Growth Fund of Amer F1

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+1.02%
IMNN - ABVX
57%
Loosely correlated
-0.19%
CLSD - ABVX
50%
Loosely correlated
+8.31%
ANEB - ABVX
50%
Loosely correlated
-1.64%
MLTX - ABVX
38%
Loosely correlated
+9.95%
XENE - ABVX
38%
Loosely correlated
+4.00%
More

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+8.31%
ABVX - CLSD
50%
Loosely correlated
+1.02%
IMNN - CLSD
30%
Poorly correlated
-0.19%
ANEB - CLSD
29%
Poorly correlated
-1.64%
BOLT - CLSD
29%
Poorly correlated
-2.00%
ACLX - CLSD
28%
Poorly correlated
+1.72%
More